← Open Payments lookup

OLIVIA EDWARDS: Open Payments

NPI 1780207795 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$684 in 32 payments from 13 companies in 2025. Trend: 2023 $2,053 · 2024 $1,983 · 2025 $684

Food & beverage: $684
CompanyPaymentsAmount
ABBVIE INC.9$163
GENZYME CORPORATION2$80
Janssen Biotech, Inc.3$74
PFIZER INC.4$71
Takeda Pharmaceuticals U.S.A., Inc.3$63
QOL Medical, LLC2$47
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$42
Aimmune Therapeutics, Inc.2$42
Intercept Pharmaceuticals, Inc.1$25
Gilead Sciences, Inc.1$22

Products named: DUPIXENT, TREMFYA, XELJANZ, ENTYVIO, RINVOQ, SKYRIZI, Sucraid, XIFAXAN.

Industry payments across MO — which companies pay providers there.